Showing results (11-20 of 162) with videos related to
Sort By:
Pageof 17
The Netherlands Journal of Medicine|December 17, 2009
Transcript profiling towards personalised medicine in rheumatoid arthritisC L VerweijBritish Journal of Rheumatology|May 1, 1997
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?B M Brinkman, T W Huizinga, S S Kurban, et al.Methods in Molecular Medicine|February 22, 2011
Molecular analysis of gene-polymorphisms affecting the host response to infectionR G Westendorp, T W HuizingaGenes and Immunity|June 27, 2001
Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individualsE L Kaijzel, J P Bayley, M V van Krugten, et al.Rheumatology (Oxford, England)|November 21, 2000
Are differences in interleukin 10 production associated with joint damage?T W Huizinga, V Keijsers, G Yanni, et al.Genes and Immunity|February 24, 2001
Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritisM V van Krugten, T W Huizinga, E L Kaijzel, et al.Clinical and Experimental Rheumatology|March 20, 1999
The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patientsM J Rood, F C Breedveld, T W HuizingaMolecular Medicine (Cambridge, Mass.)|February 5, 1999
Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritisE L Kaijzel, M V van Krugten, B M Brinkman, et al.The EMBO Journal|October 1, 1987
Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formationC L Verweij, M Hart, H PannekoekPageof 17